Brian Rosin Biography and Net Worth

U.S. Chief Financial Officer of Prenetics Global

Brian Rosin is the U.S. Chief Financial Officer. Brian leads the Company's finance organization and is responsible for financial strategy, capital allocation, investor relations support, and the financial infrastructure and unit-economics discipline required to scale a premium consumer health brand from breakout launch to durable, profitable, global category leadership.

Brian has nearly two decades of Chief Financial Officer experience, specializing in consumer e-Commerce and premium wellness subscription brands, with significant transaction experience including several successful exits. He joins Prenetics from Wellbeam Consumer Health, a nine-figure private equity-backed e-Commerce consumer wellness platform, where he served as CFO and Senior Vice President, e-Commerce Operations. Prior to Wellbeam, he was CFO of clean, plant-powered skincare brand TruSkin from 2020 through its acquisition by Wellbeam in 2021. Earlier in his career, Brian was CFO at premium supplement brand NATURELO from 2017 through its sale to Arcadia Consumer Health in 2020, and CFO and Chief Operating Officer of digital publishing business Rant, Inc from 2011 until its sale to Function(X) in 2016, where he was Chief Operating Officer until 2017.

Brian holds dual bachelor's degrees, Cum Laude, in Economics and Political Science from Northern Illinois University.

What is Brian J. Rosin's net worth?: The estimated net worth of Brian J. Rosin is at least $595.52 thousand as of August 25th, 2026. Mr. Rosin owns 23,100 shares of Prenetics Global stock worth more than $595,518 as of August 26th. This net worth evaluation does not reflect any other assets that Mr. Rosin may own. Learn More about Brian J. Rosin's net worth.
How do I contact Brian J. Rosin?: The corporate mailing address for Mr. Rosin and other Prenetics Global executives is 71 Fort Street PO Box 500, Grand Cayman E9, KY1-1106. Prenetics Global can also be reached via phone at 852-2210-9588. Learn More on Brian J. Rosin's contact information.
Has Brian J. Rosin been buying or selling shares of Prenetics Global?: During the past quarter, Brian J. Rosin has bought $497,700.00 of Prenetics Global stock. Most recently, on Tuesday, August 25th, Brian J. Rosin bought 5,100 shares of Prenetics Global stock. The stock was acquired at an average cost of $22.80 per share, with a total value of $116,280.00. Following the completion of the transaction, the chief financial officer now directly owns 23,100 shares of the company's stock, valued at $526,680. Learn More on Brian J. Rosin's trading history.
Are insiders buying or selling shares of Prenetics Global?: During the last year, Prenetics Global insiders bought shares 4 times. They purchased a total of 47,781 shares worth more than $999,777.63. The most recent insider tranaction occured on August, 25th when CFO Brian J Rosin bought 5,100 shares worth more than $116,280.00. Learn More about insider trades at Prenetics Global.
Information on this page was last updated on 8/25/2026.

Brian J. Rosin Insider Trading History at Prenetics Global

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction	Details
8/25/2026	Buy	5,100	$22.80	$116,280.00	23,100
8/24/2026	Buy	18,000	$21.19	$381,420.00	18,000

Brian J. Rosin Buying and Selling Activity at Prenetics Global

Prenetics Global Company Overview

Prenetics Global Limited, a genomics-driven health sciences company, engages in revolutionizing prevention, early detection, and treatment. It offers CircleDNA, a prevention arm that uses whole exome sequencing to offer comprehensive consumer DNA test. The company also, through its joint venture, Insighta, engages in pioneering multi-cancer early detection technologies. In addition, the company, through its equity interests in ACT Genomics Holdings Company Limited, is involved in genomic profiling of solid tumors through ACTOnco. Prenetics Global Limited was founded in 2007 and is based in Quarry Bay, Hong Kong.

Today's Range

Now: $25.78

$23.29

$26.29

50 Day Range

MA: $19.12

$16.58

$23.25

2 Week Range

Now: $25.78

$7.27

$26.29

Volume

821,980 shs

Average Volume

234,870 shs

Market Capitalization

$434.91 million

P/E Ratio

N/A

Dividend Yield